Kuchay MS, Martinez-Montoro JI, Llamoza-Torres CJ, Fernandez-Garcia JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731. doi: 10.21037/hbsn-22-355. No abstract available. PubMed PMID: 36268240; PubMed Central PMCID: PMC9577976.
AÑO: 2022; IF: 8.0
|
Re OL, Lopez-Lopez V, Balaguer-Roman A, Martinez-Sanchez MA, Eshmuminov D, Llamoza-Torres CJ, Miura K, Baroja-Mazo A, Ramirez P, Robles-Campos R, Ramos-Molina B. New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis. Langenbecks Arch Surg. 2023 Mar 31;408(1):134. doi: 10.1007/s00423-023-02867-8. PubMed PMID: 37000331.
AÑO: 2023; IF: 2.1
|
Talamantes S, Lisjak M, Gilglioni EH, Llamoza-Torres CJ, Ramos-Molina B, Gurzov EN. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Rep. 2023 Jun 9;5(9):100811. doi: 10.1016/j.jhepr.2023.100811. eCollection 2023 Sep. PubMed PMID: 37575883; PubMed Central PMCID: PMC10413159.
AÑO: 2023; IF: 9.5
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Sierra-Cruz M, Lambertos A, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Yuste JE, Martinez CM, Mika A, Frutos MD, Llamoza-Torres CJ, Cordoba-Chacon J, Ramos-Molina B. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease. J Pathol. 2024 Sep;264(1):101-111. doi: 10.1002/path.6330. Epub 2024 Jul 18. PubMed PMID: 39022853; PubMed Central PMCID: PMC11300153.
AÑO: 2024; IF: 5.6
|
Perez-Diaz AJ, Ros-Madrid I, Martinez-Sanchez MA, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Fernandez-Ruiz VE, Martinez CM, Yuste JE, Ferrer-Gomez M, Llamoza-Torres CJ, Frutos MD, Nunez-Sanchez MA, Ramos-Molina B. Alterations in hepatic amino acid metabolism related to MASLD in individuals with obesity. J Physiol Biochem. 2025 May 8. doi: 10.1007/s13105-025-01086-7. Online ahead of print. PubMed PMID: 40335876.
AÑO: 2025; IF: 3.7
|